Dr. Parfenov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
199 Reedsdale Road
Milton, MA 02186Phone+1 617-313-1480Fax+1 617-394-7725
Summary
- Dr. Valeriy Parfenov is a neurologist in Milton, MA affiliated with Beth Israel Deaconess Medical Center. He received his medical degree from Indiana University School of Medicine, completed Neurology residency at Johns Hopkins Hospital, and Multiple Sclerosis fellowship at University Hospital of Lausanne (CHUV), Switzerland. He specializes in Neuro-immunology/Multiple Sclerosis with additional clinical interests including Fibromyalgia, Intellectual Disability, Movement Disorders and General Neurology.
Education & Training
- University Hospital of Lausanne, Lausanne, SwitzerlandFellowship, Neuroimmunology & Multiple Sclerosis, 2011 - 2012
- Johns Hopkins UniversityResidency, Neurology, 2008 - 2011
- Ascension St Vincent Hospital IndianapolisInternship, Internal Medicine, 2007 - 2008
- Indiana University School of MedicineClass of 2007
Certifications & Licensure
- MA State Medical License 2012 - 2025
- MO State Medical License 2011 - 2014
- IN State Medical License 2011 - 2013
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2 citationsManagement of Fulminant Multiple Sclerosis With Rituximab: A Case Report.Valeriy Parfenov, Renaud Du Pasquier, Myriam Schluep
The Neurologist. 2015-06-01 - 9 citationsAssessing risks of multiple sclerosis therapiesValeriy Parfenov, Myriam Schluep, Renaud Du Pasquier
Journal of the Neurological Sciences. 2013-09-15
Journal Articles
- Management of fulminant multiple sclerosis with rituximab: a case reportValeriy Parfenov, Renaud Du Pasquier, Myriam Schluep, The Neurologist, 6/19/2015
- Assessing risks of multiple sclerosis therapies.Parfenov V, Schluep M, Du Pasquier R., Journal of Neurological Sciences, 7/5/2013
- Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.Ludigs K, Parfenov V, Du Pasquier RA, Guarda G., Cell Mol Life Sci, 4/24/2012
Books/Book Chapters
Other Languages
- Russian, Ukrainian, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: